Report - Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form